Cooley advised Inscripta on the deal. Inscripta, a global leader in genome engineering technology, announced its acquisition of Infinome Biosciences and Sestina Bio. These acquisitions advance Inscripta’s...
Inscripta’s Acquisition of Infinome Biosciences and Sestina Bio
Velocity Global’s $400 Million Series B Financing Round
Cooley advised Velocity Global on the deal. Velocity Global, a leading provider of global talent solutions, announced its $400 million Series B financing round. With the fundraise,...